Announcements Trials
Browse Landscape

Phase

Phase NA 12Phase 4 6Phase 3 5Phase 2 4Phase 1 2Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Polycystic Ovary Syndrome 6Squamous Cell Carcinoma of Head and Neck 2Obesity 2Endometrial Neoplasms 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Thoracic Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Lymphoid Interstitial Pneumonia 1Laryngeal Diseases 1Insulin Resistance 1Inflammation 1Head and Neck Squamous Cell Cancer 1Head and Neck Neoplasms 1Glioblastoma 1Diabetes Mellitus 1Barrett Esophagus 1

Interventions

Tirzepatide 1Tablets 1Pioglitazone 1Metformin 1Insulin, Regular, Human 1Insulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Insulin Resistance × Metformin × Clear all
NCT01205672 2017-06-02

Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed
21 enrolled
Gynecologic

Insulin Resistance, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡